Cronos Group plans to focus most of its production on derivative products, and it would only be logical if Altria, the company that sunk $1.8 billion into Cronos for a 45% stake, aided with that development process.
Interesting article about the possible future of the cannabis vape market. The author makes some good points about Altria and Cronos Group, the path they may be heading down. I continue to sell the out of the money covered calls on Cronos though, the stock just doesn't seem to want to go above $16.00.....
Read the full story here....
https://finance.yahoo.com/news/4-must-know-cannabis-vape-132100737.html